This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dorian, P. Articles by Feindel, C. Search for Related Content PubMed PubMed Citation Articles by Dorian, P. Articles by Feindel, C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Circulation, Vol 83, 614-621, Copyright © 1991 by American Heart Association

ARTICLES

Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model

P Dorian, M Wang, I David and C Feindel
Department of Medicine, Toronto Western Hospital, Ontario, Canada.

The effect of long-term oral administration of antiarrhythmic drugs on defibrillation energy requirements is not well understood. We examined the effect of clofilium, a drug that prolongs cardiac action potential duration without slowing cardiac conduction, on defibrillation energy requirements and ventricular effective refractory periods in a canine model during a 3-week period. Epicardial patch electrodes were implanted in 12 dogs, and baseline testing was conducted under fentanyl anesthesia on day 7. An oral clofilium (100 mg/day) regimen was started on day 8. Six clofilium-treated and six control dogs underwent repeated testing on days 14, 21, and 28 after surgery. Truncated trapezoidal shocks were given repeatedly at various stored energies in random order; delivered current and impedance were measured; and delivered energy was calculated. The energy and current for 50% success in defibrillation (E50 and I50, respectively) were determined. For control animals, E50 increased by a mean 34 +/- 78%, 60 +/- 83%, and 69 +/- 122% compared with baseline (day 7) on days 14, 21, and 28, respectively. In contrast, E50 in clofilium-treated dogs decreased by 39 +/- 62%, 24 +/- 33%, and 32 +/- 15% on days 14, 21, and 28, respectively. Mean current requirements (I50) remained relatively stable compared with baseline in control animals (-7 +/- 39%, +25 +/- 36%, +40 +/- 75% on days 14, 21, and 28, respectively). After clofilium administration I50 decreased by 36 +/- 22%, 32 +/- 17%, and 33 +/- 17% on days 14, 21, and 28, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J.-q. Zhong, G. Laurent, P. P.-S. So, Xudong Hu, J. K. Hennan, and P. Dorian Effects of Rotigaptide, a Gap Junction Modifier, on Defibrillation Energy and Resuscitation From Cardiac Arrest in Rabbits Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 69 - 77. [Abstract] [PDF]

				J. Huang, J. L. Skinner, J. M. Rogers, W. M. Smith, W. L. Holman, and R. E. Ideker The effects of acute and chronic amiodarone on activation patterns and defibrillation threshold during ventricular fibrillation in dogs J. Am. Coll. Cardiol., July 17, 2002; 40(2): 375 - 383. [Abstract] [Full Text] [PDF]

				X. Qi, P. Varma, D. Newman, and P. Dorian Gap Junction Blockers Decrease Defibrillation Thresholds Without Changes in Ventricular Refractoriness in Isolated Rabbit Hearts Circulation, September 25, 2001; 104(13): 1544 - 1549. [Abstract] [Full Text] [PDF]

				A. P. Winecoff, J. J. Sims, M. L. Markel, and M. R. Ujhelyi Pinacidil's Effects on Defibrillation Outcomes: Role of Increased Potassium Conductance Via the KATP Channel Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(3): 171 - 180. [Abstract] [PDF]

				M. R. Ujhelyi, M. Schur, T. Frede, M. Gabel, and M. L. Markel Differential Effects of Lidocaine on Defibrillation Threshold With Monophasic Versus Biphasic Shock Waveforms Circulation, September 15, 1995; 92(6): 1644 - 1650. [Abstract] [Full Text]